Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations
The efficacy of naftidrofuryl in treating cerebrovascular diseases is analyzed on the basis of a review of the Russian and foreign literature. Naftidrofuryl is a seroton 5-HT2 receptor antagonist and acts on brain energy metabolism mainly during hypoxia or ischemia. The results of preclinical studie...
Main Authors: | A. N. Belova, D. N. Shakurova, E. V. Gayazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-01-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/567 |
Similar Items
-
PHARMACOECONOMIC EFFECTIVENESS OF NAFTIDROFURYL IN PATIENTS WITH ISCHEMIC STROKE
by: A. N. Bogolepova, et al.
Published: (2017-07-01) -
Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia
by: M. N. Dadasheva, et al.
Published: (2021-02-01) -
Pharmacoeconomic analysis of naftidrofuryl for treatment of ischemic stroke
by: A. E. Cheberda, et al.
Published: (2018-05-01) -
NAFTIDROFURYL USE IN MODERATE VASCULAR COGNITIVE DISORDERS
by: V. A. Parfenov, et al.
Published: (2017-12-01) -
Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
by: Marta Kus-Slowinska, et al.
Published: (2020-12-01)